News

Why Johnson & Johnson Could Be a Safe Long-Term Bet for Your Portfolio?
Johnson & Johnson is a globally diversified healthcare conglomerate with two main operating segments. The Innovative Medicine ...
STAT4h
The murkiness of drug companies’ price transparency reports
Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.
Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
From AI To Emerging Markets: How 6 Pros Would Allocate $10K In Today's Market
J.P. Morgan Asset Management Chief Market Strategist for the Americas Gabriela Santos said that she would allocate $7,000 to ...
TMCnet1h
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
Advisors XOMA Royalty was represented by Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V, who acted as U.S. and Dutch legal advisors, respectively. Leerink Partners is acting as exclusive financial ...
Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement
Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the ...
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...